(Q37057079)

18 August 2017

Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A591982

14 July 2022

1 reference

10.1136/JNNP.40.12.1142

https://api.crossref.org/works/10.1136/JNNP.40.12.1142

27 July 2023

author name string

T. A. Caraceni

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A591982

14 July 2022

I. Celano

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A591982

14 July 2022

E. Parati

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A591982

14 July 2022

F. Girotti

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A591982

14 July 2022

language of work or name

English

0 references

publication date

1 December 1977

1 reference

PMC publication ID

492936

full work available at URL

18 August 2017

https://europepmc.org/articles/PMC492936

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A591982

https://europepmc.org/articles/PMC492936?pdf=render

14 July 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A591982

https://syndication.highwire.org/content/doi/10.1136/jnnp.40.12.1142

14 July 2022

1 reference

Crossref

DOI

10.1136/JNNP.40.12.1142

https://api.crossref.org/works/10.1136/JNNP.40.12.1142

Journal of Neurology, Neurosurgery and Psychiatry

27 July 2023

published in

1 reference

18 August 2017

40

1 reference

18 August 2017

12

1 reference

18 August 2017

1142-1146

1 reference

Treatment of parkinson's disease with bromocriptine

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492936

The antiparkinsonian efficacy of bromocriptine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492936

Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492936

Bromocriptine treatment in Parkinson's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492936

Treatment of parkinsonian syndromes by bromocriptin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492936

Studies with bromocriptine: III. Concomitant administration of caffeine to patients with idiopathic parkinsonism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492936

Modification of involuntary movements by centrally acting drugs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492936

Studies on the antiparkinsonian efficacy of lergotrile

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492936

Bromocriptine and levodopa (with or without carbidopa) in parkinsonism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492936

Evidence for a luteolytic function of prolactin in the intact cyclic rat using 2-Br-α-ergokryptine (CB 154)

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492936

Bromocriptine in Parkinsonism.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492936

Long-lasting anti-tremor induced by 2-Br-alpha-ergocryptine in monkeys

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492936

Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492936

27 June 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/591982

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/591982

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[2-Br-alpha-ergokryptin: influence on fertility and lactation in the rat]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/591982

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/JNNP.40.12.1142

1 reference

18 August 2017

1 reference

PMC publication ID

492936

18 August 2017

1 reference

PMC publication ID

492936